I've been able to find two conferences PRR will be attending in the near future.
Bio Asia Partnering Conference. Jan 24-25. Tokyo http://www.bio.org/bioasia/companies/2010participatingcompanies.aspx
BIT Life Science Conference. March 23-25. Beijing. http://www.bitlifesciences.com/ica2011/ http://www.bitlifesciences.com/ica2011/program.asp#t5 (Definitely presenting at this one)
Clearly the success of the NASDAQ listing long term depends on successful clinical trials.
But trials take years and the SP of biotechs tends to drift during times with few meaningful announcements.
So ongoing SP strength may depend to some degree on PRR management exciting and maintaining interest among the broking/investment community and potential funding, partnering and licencing partners.
I'm pleased to see PRR keeping the company brand visible at these conferences and hope its a trend they intend to continue.
PRR Price at posting:
19.1¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)